C-Rad AB (publ) (CRAD-B.ST)
SEK 29.9
(-0.17%)
SEK 29.9
(-0.17%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -127.6 Million SEK | -8.3% |
| 2022 | -117.82 Million SEK | -1.53% |
| 2021 | -116.04 Million SEK | -15.34% |
| 2020 | -100.6 Million SEK | -995.24% |
| 2019 | -9.18 Million SEK | 1.58% |
| 2018 | -9.33 Million SEK | 36.05% |
| 2017 | -14.59 Million SEK | -1609.4% |
| 2016 | -853.74 Thousand SEK | -110.17% |
| 2015 | 8.39 Million SEK | -7.17% |
| 2014 | 9.04 Million SEK | 626.86% |
| 2013 | 1.24 Million SEK | -6.69% |
| 2012 | 1.33 Million SEK | 108.26% |
| 2011 | -16.14 Million SEK | -24.87% |
| 2010 | -12.92 Million SEK | -1778.77% |
| 2009 | 769.94 Thousand SEK | 105.99% |
| 2008 | -12.85 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -118.7 Million SEK | 23.07% |
| 2024 Q2 | -140.9 Million SEK | 3.03% |
| 2024 Q1 | -145.3 Million SEK | -13.87% |
| 2023 Q4 | -127.6 Million SEK | -47.69% |
| 2023 Q3 | -86.4 Million SEK | -7.73% |
| 2023 Q2 | -80.2 Million SEK | 21.37% |
| 2023 Q1 | -102 Million SEK | 13.43% |
| 2023 FY | -127.6 Million SEK | -8.3% |
| 2022 Q3 | -91.1 Million SEK | 11.55% |
| 2022 Q1 | -109.5 Million SEK | 5.64% |
| 2022 FY | -117.82 Million SEK | -1.53% |
| 2022 Q2 | -103 Million SEK | 5.94% |
| 2022 Q4 | -117.82 Million SEK | -29.33% |
| 2021 Q4 | -116.04 Million SEK | -11.69% |
| 2021 FY | -116.04 Million SEK | -15.34% |
| 2021 Q2 | -106.8 Million SEK | -2.1% |
| 2021 Q3 | -103.9 Million SEK | 2.72% |
| 2021 Q1 | -104.6 Million SEK | -3.97% |
| 2020 FY | -100.6 Million SEK | -995.24% |
| 2020 Q1 | -87.2 Million SEK | -849.27% |
| 2020 Q2 | -82.4 Million SEK | 5.5% |
| 2020 Q3 | -86.7 Million SEK | -5.22% |
| 2020 Q4 | -100.6 Million SEK | -16.04% |
| 2019 Q4 | -9.18 Million SEK | 69.48% |
| 2019 Q2 | -14.8 Million SEK | 37.55% |
| 2019 Q1 | -23.7 Million SEK | -153.94% |
| 2019 FY | -9.18 Million SEK | 1.58% |
| 2019 Q3 | -30.1 Million SEK | -103.38% |
| 2018 Q3 | -8 Million SEK | -26.98% |
| 2018 Q2 | -6.3 Million SEK | -14.55% |
| 2018 Q1 | -5.5 Million SEK | 62.31% |
| 2018 FY | -9.33 Million SEK | 36.05% |
| 2018 Q4 | -9.33 Million SEK | -16.66% |
| 2017 Q1 | -3.39 Million SEK | -297.66% |
| 2017 Q4 | -14.59 Million SEK | 17.08% |
| 2017 FY | -14.59 Million SEK | -1609.4% |
| 2017 Q3 | -17.6 Million SEK | -781.91% |
| 2017 Q2 | 2.58 Million SEK | 176.02% |
| 2016 FY | -853.74 Thousand SEK | -110.17% |
| 2016 Q4 | -853.74 Thousand SEK | -114.0% |
| 2016 Q2 | -3.76 Million SEK | -173.34% |
| 2016 Q1 | 5.13 Million SEK | -38.79% |
| 2016 Q3 | 6.09 Million SEK | 261.85% |
| 2015 Q1 | 12.28 Million SEK | 35.85% |
| 2015 FY | 8.39 Million SEK | -7.17% |
| 2015 Q4 | 8.39 Million SEK | 17.35% |
| 2015 Q3 | 7.15 Million SEK | 818.2% |
| 2015 Q2 | 779.23 Thousand SEK | -93.66% |
| 2014 Q3 | 7.05 Million SEK | 705.93% |
| 2014 Q4 | 9.04 Million SEK | 28.12% |
| 2014 Q1 | -3.67 Million SEK | -395.61% |
| 2014 FY | 9.04 Million SEK | 626.86% |
| 2014 Q2 | 875.94 Thousand SEK | 123.81% |
| 2013 Q1 | 11.24 Million SEK | 742.92% |
| 2013 Q4 | 1.24 Million SEK | -76.94% |
| 2013 FY | 1.24 Million SEK | -6.69% |
| 2013 Q2 | -8.65 Million SEK | -176.95% |
| 2013 Q3 | 5.39 Million SEK | 162.37% |
| 2012 Q4 | 1.33 Million SEK | 124.73% |
| 2012 Q3 | -5.39 Million SEK | 49.1% |
| 2012 FY | 1.33 Million SEK | 108.26% |
| 2012 Q1 | -15.81 Million SEK | 2.04% |
| 2012 Q2 | -10.59 Million SEK | 32.98% |
| 2011 Q4 | -16.14 Million SEK | -583.63% |
| 2011 FY | -16.14 Million SEK | -24.87% |
| 2011 Q1 | -11.8 Million SEK | 8.7% |
| 2011 Q2 | -4.11 Million SEK | 65.17% |
| 2011 Q3 | -2.36 Million SEK | 42.55% |
| 2010 FY | -12.92 Million SEK | -1778.77% |
| 2010 Q3 | -9.47 Million SEK | 35.62% |
| 2010 Q1 | -4.18 Million SEK | -644.07% |
| 2010 Q2 | -14.71 Million SEK | -251.32% |
| 2010 Q4 | -12.92 Million SEK | -36.42% |
| 2009 Q4 | 769.94 Thousand SEK | 207.23% |
| 2009 Q2 | -5.3 Million SEK | -22.03% |
| 2009 Q1 | -4.34 Million SEK | 66.17% |
| 2009 FY | 769.94 Thousand SEK | 105.99% |
| 2009 Q3 | -718 Thousand SEK | 86.47% |
| 2008 FY | -12.85 Million SEK | 0.0% |
| 2008 Q4 | -12.85 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acarix AB (publ) | -35.14 Million SEK | -263.026% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 110.4% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 110.4% |
| Arcoma AB | -1.12 Million SEK | -11212.057% |
| Bactiguard Holding AB (publ) | 109.88 Million SEK | 216.125% |
| BICO Group AB (publ) | 927.9 Million SEK | 113.751% |
| Boule Diagnostics AB (publ) | 128.8 Million SEK | 199.068% |
| CellaVision AB (publ) | -56.94 Million SEK | -124.088% |
| Clinical Laserthermia Systems AB (publ) | -14.87 Million SEK | -757.7% |
| Chordate Medical Holding AB (publ) | -8.45 Million SEK | -1409.129% |
| Duearity AB (publ) | 10.23 Million SEK | 1347.19% |
| Dignitana AB (publ) | 13.07 Million SEK | 1075.759% |
| Episurf Medical AB (publ) | -52.7 Million SEK | -142.125% |
| Getinge AB (publ) | 5.4 Billion SEK | 102.359% |
| Scandinavian Real Heart AB (Publ) | -35.05 Million SEK | -264.019% |
| Iconovo AB (publ) | -10.75 Million SEK | -1086.388% |
| Integrum AB (publ) | -10.47 Million SEK | -1117.96% |
| Luxbright AB (publ) | -13.83 Million SEK | -822.401% |
| Mentice AB (publ) | -49.56 Million SEK | -157.445% |
| OssDsign AB (publ) | -162.78 Million SEK | 21.616% |
| Paxman AB (publ) | -11.41 Million SEK | -1018.219% |
| Promimic AB (publ) | -50.32 Million SEK | -153.562% |
| Qlife Holding AB (publ) | 19.07 Million SEK | 769.114% |
| SciBase Holding AB (publ) | -27.32 Million SEK | -366.989% |
| ScandiDos AB (publ) | -1.53 Million SEK | -8234.422% |
| Sectra AB (publ) | -772.85 Million SEK | 83.49% |
| Sedana Medical AB (publ) | -226.87 Million SEK | 43.757% |
| Senzime AB (publ) | -139.54 Million SEK | 8.557% |
| SpectraCure AB (publ) | -50.23 Million SEK | -154.011% |
| Stille AB | -178.5 Million SEK | 28.517% |
| Vitrolife AB (publ) | 1.22 Billion SEK | 110.391% |
| Xvivo Perfusion AB (publ) | -214.65 Million SEK | 40.555% |